Dulai, Parambir S.
Osterman, Mark T.
Lasch, Karen
Cao, Charlie
Riaz, Faisal
Sandborn, William J.
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A., Inc.
Article History
Received: 27 April 2018
Accepted: 18 March 2019
First Online: 28 March 2019
Compliance with Ethical Standards
:
: MTO reports: research grant from UCB; consulting fees from AbbVie, Janssen, Lycera, Merck, Pfizer, Takeda, UCB. WJS reports: research grants from Atlantic Healthcare Limited, Amgen, Genentech, Gilead Sciences, AbbVie, Janssen, Takeda, Lilly, Celgene/Receptos; consulting fees from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Celgene, Conatus, Cosmo, Escalier Biosciences, Ferring, Genentech, Gilead, Janssen, Lilly, Miraca Life Sciences, Nivalis Therapeutics, Novartis, Nutrition Science Partners, Oppilan Pharma, Otsuka, Paul Hastings, Pfizer, Precision IBD, Progenity, Prometheus Laboratories, Ritter Pharmaceuticals, Robarts Clinical Trials, Salix, Shire, Seres Therapeutics, Sigmoid Biotechnologies, Takeda, TiGenix, Tillotts Pharma, UCB, Vivelix; and stock options from Ritter Pharmaceuticals, Oppilan Pharma, Escalier Biosciences, Precision IBD, Progenity. PSDĀ reports: research support from Takeda and Pfizer; consulting and travel support from Takeda. CC, FR, and KL are employees of Takeda Pharmaceuticals USA.